277 related articles for article (PubMed ID: 12351425)
21. Oral treatment with vanadium of Zucker fatty rats activates muscle glycogen synthesis and insulin-stimulated protein phosphatase-1 activity.
Semiz S; McNeill JH
Mol Cell Biochem; 2002 Jul; 236(1-2):123-31. PubMed ID: 12190110
[TBL] [Abstract][Full Text] [Related]
22. Increased insulin receptor signaling and glycogen synthase activity contribute to the synergistic effect of exercise on insulin action.
Christ-Roberts CY; Pratipanawatr T; Pratipanawatr W; Berria R; Belfort R; Mandarino LJ
J Appl Physiol (1985); 2003 Dec; 95(6):2519-29. PubMed ID: 12909611
[TBL] [Abstract][Full Text] [Related]
23. Normalization of skeletal muscle glycogen synthesis and glycolysis in rosiglitazone-treated Zucker fatty rats: an in vivo nuclear magnetic resonance study.
Jucker BM; Schaeffer TR; Haimbach RE; McIntosh TS; Chun D; Mayer M; Ohlstein DH; Davis HM; Smith SA; Cobitz AR; Sarkar SK
Diabetes; 2002 Jul; 51(7):2066-73. PubMed ID: 12086934
[TBL] [Abstract][Full Text] [Related]
24. Exercise training attenuated the PKB and GSK-3 dephosphorylation in the myocardium of ZDF rats.
Lajoie C; Calderone A; Trudeau F; Lavoie N; Massicotte G; Gagnon S; Béliveau L
J Appl Physiol (1985); 2004 May; 96(5):1606-12. PubMed ID: 14698990
[TBL] [Abstract][Full Text] [Related]
25. Long-term treatment with the dipeptidyl peptidase IV inhibitor P32/98 causes sustained improvements in glucose tolerance, insulin sensitivity, hyperinsulinemia, and beta-cell glucose responsiveness in VDF (fa/fa) Zucker rats.
Pospisilik JA; Stafford SG; Demuth HU; Brownsey R; Parkhouse W; Finegood DT; McIntosh CH; Pederson RA
Diabetes; 2002 Apr; 51(4):943-50. PubMed ID: 11916911
[TBL] [Abstract][Full Text] [Related]
26. Hyperglycemia markedly enhances skeletal muscle glycogen synthase activity in diabetic, but not in normal conscious rats.
Farrace S; Rossetti L
Diabetes; 1992 Nov; 41(11):1453-63. PubMed ID: 1397721
[TBL] [Abstract][Full Text] [Related]
27. Dysregulation of glycogen synthase kinase-3 in skeletal muscle and the etiology of insulin resistance and type 2 diabetes.
Henriksen EJ
Curr Diabetes Rev; 2010 Sep; 6(5):285-93. PubMed ID: 20594161
[TBL] [Abstract][Full Text] [Related]
28. Decreased insulin action in skeletal muscle from patients with McArdle's disease.
Nielsen JN; Vissing J; Wojtaszewski JF; Haller RG; Begum N; Richter EA
Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1267-75. PubMed ID: 12006356
[TBL] [Abstract][Full Text] [Related]
29. A new antidiabetic agent (JTT-501) rapidly stimulates glucose disposal rates by enhancing insulin signal transduction in skeletal muscle.
Maegawa H; Obata T; Shibata T; Fujita T; Ugi S; Morino K; Nishio Y; Kojima H; Hidaka H; Haneda M; Yasuda H; Kikkawa R; Kashiwagi A
Diabetologia; 1999 Feb; 42(2):151-9. PubMed ID: 10064094
[TBL] [Abstract][Full Text] [Related]
30. Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies.
Goldfine AB; Patti ME; Zuberi L; Goldstein BJ; LeBlanc R; Landaker EJ; Jiang ZY; Willsky GR; Kahn CR
Metabolism; 2000 Mar; 49(3):400-10. PubMed ID: 10726921
[TBL] [Abstract][Full Text] [Related]
31. Vasopeptidase inhibitor omapatrilat induces profound insulin sensitization and increases myocardial glucose uptake in Zucker fatty rats: Studies comparing a vasopeptidase inhibitor, angiotensin-converting enzyme inhibitor, and angiotensin II type I receptor blocker.
Wang CH; Leung N; Lapointe N; Szeto L; Uffelman KD; Giacca A; Rouleau JL; Lewis GF
Circulation; 2003 Apr; 107(14):1923-9. PubMed ID: 12668518
[TBL] [Abstract][Full Text] [Related]
32. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
33. Long-term treatment with novel glycogen synthase kinase-3 inhibitor improves glucose homeostasis in ob/ob mice: molecular characterization in liver and muscle.
Kaidanovich-Beilin O; Eldar-Finkelman H
J Pharmacol Exp Ther; 2006 Jan; 316(1):17-24. PubMed ID: 16169938
[TBL] [Abstract][Full Text] [Related]
34. Peroxisome proliferator-activated receptor (PPAR)-alpha agonism prevents the onset of type 2 diabetes in Zucker diabetic fatty rats: A comparison with PPAR gamma agonism.
Bergeron R; Yao J; Woods JW; Zycband EI; Liu C; Li Z; Adams A; Berger JP; Zhang BB; Moller DE; Doebber TW
Endocrinology; 2006 Sep; 147(9):4252-62. PubMed ID: 16728496
[TBL] [Abstract][Full Text] [Related]
35. Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats.
Rossetti L; Giaccari A
J Clin Invest; 1990 Jun; 85(6):1785-92. PubMed ID: 2189891
[TBL] [Abstract][Full Text] [Related]
36. Effects of adrenaline on whole-body glucose metabolism and insulin-mediated regulation of glycogen synthase and PKB phosphorylation in human skeletal muscle.
Jensen J; Ruge T; Lai YC; Svensson MK; Eriksson JW
Metabolism; 2011 Feb; 60(2):215-26. PubMed ID: 20153492
[TBL] [Abstract][Full Text] [Related]
37. Caffeine-induced impairment of insulin action but not insulin signaling in human skeletal muscle is reduced by exercise.
Thong FS; Derave W; Kiens B; Graham TE; Ursø B; Wojtaszewski JF; Hansen BF; Richter EA
Diabetes; 2002 Mar; 51(3):583-90. PubMed ID: 11872654
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of insulin-stimulated glycogen synthesis by 5-aminoimidasole-4-carboxamide-1-beta-d-ribofuranoside-induced adenosine 5'-monophosphate-activated protein kinase activation: interactions with Akt, glycogen synthase kinase 3-3alpha/beta, and glycogen synthase in isolated rat soleus muscle.
Fediuc S; Gaidhu MP; Ceddia RB
Endocrinology; 2006 Nov; 147(11):5170-7. PubMed ID: 16873531
[TBL] [Abstract][Full Text] [Related]
39. Insulin promotes glycogen synthesis in the absence of GSK3 phosphorylation in skeletal muscle.
Bouskila M; Hirshman MF; Jensen J; Goodyear LJ; Sakamoto K
Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E28-35. PubMed ID: 18003720
[TBL] [Abstract][Full Text] [Related]
40. Hyperglycaemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with type 2 (non-insulin-dependent) diabetes mellitus.
Vaag A; Damsbo P; Hother-Nielsen O; Beck-Nielsen H
Diabetologia; 1992 Jan; 35(1):80-8. PubMed ID: 1541385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
